EUVIMEDEUVIMED entdecken
Systematische Übersicht

Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review

Damian Skrypnik iD, Katarzyna Skrypnik iD, Joanna Suliburska iD, Paweł Bogdański iD

Obesity Reviews · 2023

DOI: 10.1111/obr.13575 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Obesity Reviews, 2023. Verfasst von Damian Skrypnik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznań University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Leptin, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Narodowym Centrum Nauki, Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

By 2030, it is expected that a billion people will have suffer from obesity. Adipose tissue synthesizes leptin, an adipokine that affects cardiovascular risk. Leptin intensifies the synthesis of vascular endothelial growth factor (VEGF). Our study reviews recent reports on leptin–VEGF crosstalk in obesity and related disorders. PubMed, Web of Science, Scopus, and Google Scholar were searched. One hundred and one articles involving human, animal, and in vitro research were included. In vitro studies show the crucial role of interaction between endothelial cells and adipocytes and hypoxia as a factor that intensifies leptin's effects on VEGF. Leptin–VEGF crosstalk promotes the progression of cancer. The animal research reveal that a high‐fat diet enhances leptin and VEGF crosstalk. Genetic and epigenetic mechanisms and procreator‐offspring programming may be involved in leptin–VEGF crosstalk. Some female‐specific characteristics of leptin–VEGF relation in obesity were observed. The human studies have shown that increased leptin and VEGF synthesis and leptin–VEGF crosstalk are factors linking obesity with elevated cardiovascular risk. The studies of the last 10 years documented a range of significant aspects of leptin–VEGF crosstalk specific for obesity and related disorders, shedding new light on the link between obesity and increased cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinVascular Endothelial Growth Factor AAnimalsFemaleHumansEndothelial CellsVascular Endothelial Growth FactorsObesity

Stichwörter der Autor:innen

VEGFleptinobesityvascular endothelial growth factor

Substanzen

LeptinVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Autor:innen und Institutionen

  • Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznań University of Medical Sciences, Poznań, Poland.
  • Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland.

ORCID-Profile: Damian Skrypnik, Katarzyna Skrypnik, Joanna Suliburska, Paweł Bogdański

Förderung

  • Narodowym Centrum Nauki
  • Narodowe Centrum Nauki

Zitieren

APA

Skrypnik, D., Skrypnik, K., Suliburska, J., & Bogdański, P. (2023). Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review. Obesity Reviews. https://doi.org/10.1111/obr.13575

Vancouver

Skrypnik D, Skrypnik K, Suliburska J, Bogdański P. Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review. Obesity Reviews. 2023. doi:10.1111/obr.13575

BibTeX
@article{Skrypnik2023,
  author = {Skrypnik, Damian and Skrypnik, Katarzyna and Suliburska, Joanna and Bogdański, Paweł},
  title = {Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review},
  journal = {Obesity Reviews},
  year = {2023},
  doi = {10.1111/obr.13575}
}
Kostenlos starten →